PAXG Out in the Country
NCT04480268
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
175
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
DRUG:
PAXG regimen (cisplatin, nab-paclitaxel, capecitabine, gemcitabine) chemotherapy
Sponsor
IRCCS San Raffaele